Allarity Therapeutics, Inc.
ALLR Healthcare Biotechnology
Allarity Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $320,000.00. In the quarter to June 2026, EPS fell 40.0%, free cash flow grew 53.2% and total debt rose 3.56%, each against the same quarter a year earlier.
Follow ALLR
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
16.90 | 14.69 | 29.81 | 26.98 |
Receivables |
1.66 | 0.87 | 1.08 | 1.31 | |
Other current assets |
0.11 | 0.27 | 0.11 | 0.06 | |
Total current assets |
20.47 | 17.93 | 34.50 | 31.73 | |
Property, Plant, Equpment (Net) |
0.33 | 0.33 | 0.42 | 0.39 | |
Total non-current assets |
0.33 | 0.33 | 0.42 | 0.39 | |
Total Assets |
20.80 | 18.26 | 34.92 | 32.12 | |
Notes Payable |
— | — | 20.08 | 20.86 | |
Accounts Payable |
4.60 | 4.28 | 4.24 | 4.11 | |
Accrued Expenses |
2.71 | 2.67 | 2.19 | 1.97 | |
Current Part of Debt |
1.39 | 1.40 | 1.42 | 1.42 | |
Current Part of Taxes to Pay |
0.08 | 0.08 | 0.08 | 0.08 | |
Other current liabilities |
— | — | — | 0.13 | |
Total current liabilities |
8.79 | 8.43 | 28.00 | 28.58 | |
Total non-current liabilities |
— | — | — | — | |
Total liabilities |
8.79 | 8.43 | 28.00 | 28.58 | |
Additional Paid In Capital |
143.84 | 144.23 | 144.40 | 144.68 | |
Common Stock (Net) |
0.00 | 0.00 | 0.00 | 0.00 | |
Retained Earnings |
(126.82) | (130.20) | (132.95) | (136.35) | |
Treasury Stock |
2.71 | 3.19 | 3.45 | 3.45 | |
Common Equity (Total) |
12.01 | 9.83 | 6.92 | 3.54 | |
Shareholders Equity (Total) |
12.01 | 9.83 | 6.92 | 3.54 | |
Shareholders Equity and Liabilities (Total) |
20.80 | 18.26 | 34.92 | 32.12 | |
Shares (Common) |
16.11 | 16.08 | 15.82 | 15.91 | |
Shareholders Equity (Tangible) |
12.01 | 9.83 | 6.92 | 3.54 | |
Net Debt |
(15.50) | (13.29) | (28.40) | (25.56) | |
Total Debt |
1.39 | 1.40 | 1.42 | 1.42 |